RocketTickers

Clearside Biomedical Announces Positive Safety Results from Coho

Long
NASDAQ:CLSD   Clearside Biomedical, Inc.
CLSD: Clearside Biomedical, Inc.
2021-06-15 07:05:00
Clearside Biomedical Announces Positive Safety Results from Cohort 1 of OASIS Phase 1/2a Clinical Trial of CLS-AX (axitinib injectable suspension) for the Treatment of Wet AMD
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.